1. Home
  2. DNOW vs EVO Comparison

DNOW vs EVO Comparison

Compare DNOW & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNOW
  • EVO
  • Stock Information
  • Founded
  • DNOW 1862
  • EVO 1993
  • Country
  • DNOW United States
  • EVO Germany
  • Employees
  • DNOW N/A
  • EVO N/A
  • Industry
  • DNOW Metal Fabrications
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DNOW Industrials
  • EVO Health Care
  • Exchange
  • DNOW Nasdaq
  • EVO Nasdaq
  • Market Cap
  • DNOW 1.8B
  • EVO 1.4B
  • IPO Year
  • DNOW N/A
  • EVO 2021
  • Fundamental
  • Price
  • DNOW $14.40
  • EVO $3.98
  • Analyst Decision
  • DNOW Buy
  • EVO Buy
  • Analyst Count
  • DNOW 2
  • EVO 2
  • Target Price
  • DNOW $17.50
  • EVO $5.90
  • AVG Volume (30 Days)
  • DNOW 862.7K
  • EVO 200.1K
  • Earning Date
  • DNOW 05-07-2025
  • EVO 05-06-2025
  • Dividend Yield
  • DNOW N/A
  • EVO N/A
  • EPS Growth
  • DNOW N/A
  • EVO N/A
  • EPS
  • DNOW 0.75
  • EVO N/A
  • Revenue
  • DNOW $2,409,000,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • DNOW $4.26
  • EVO $10.08
  • Revenue Next Year
  • DNOW $5.30
  • EVO $10.99
  • P/E Ratio
  • DNOW $19.24
  • EVO N/A
  • Revenue Growth
  • DNOW 4.74
  • EVO 1.50
  • 52 Week Low
  • DNOW $11.42
  • EVO $2.84
  • 52 Week High
  • DNOW $18.45
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • DNOW 38.26
  • EVO 49.18
  • Support Level
  • DNOW $14.26
  • EVO $3.78
  • Resistance Level
  • DNOW $14.98
  • EVO $4.05
  • Average True Range (ATR)
  • DNOW 0.31
  • EVO 0.15
  • MACD
  • DNOW -0.06
  • EVO -0.04
  • Stochastic Oscillator
  • DNOW 9.56
  • EVO 19.61

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: